Congress lets AI read mammograms without a doctor's sign-off

What it does

This bill amends federal mammography quality standards to permit AI systems to interpret mammograms alongside or instead of physicians. It modifies the Public Health Service Act to allow 'machine-learning or artificial intelligence system[s]' to serve as the interpreting entity in mammography facilities, removing the requirement that a physician personally sign the interpretation.

Why we flagged it

The bill functionally permits AI systems to replace physician interpretation in mammography without establishing validation, liability, or oversight standards. It is a regulatory carve-out for AI vendors, not a quality-improvement measure—the title frames it as 'updating standards' but the operative text removes a protective standard (physician interpretation) rather than adding one.

What the text implies

• Removes statutory physician signature requirement without establishing who is liable if an AI misses cancer or produces a false positive—liability may shift to patients or facilities rather than AI vendors.
• Does not require FDA pre-market validation, ongoing performance monitoring, or transparency about AI error rates—facilities could deploy unvetted systems immediately.
• Creates a two-tier diagnostic system: wealthy/informed patients may demand physician review; others receive AI-only interpretation without knowing the difference.
• Permits facilities to reduce physician staffing and shift costs to AI, potentially lowering quality while improving facility margins—financial incentive misaligned with patient safety.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Patients lose the statutory guarantee of physician interpretation and oversight of mammography results—a critical diagnostic step in cancer detection. While AI may eventually prove equivalent or superior, removing the physician requirement without establishing AI validation standards, liability frameworks, or mandatory physician review creates a regulatory gap that shifts diagnostic risk to patients without their informed consent or knowledge.

Who stands to gain

• AI/machine-learning vendors in medical imaging
• mammography facility operators (reduced physician labor costs)
• healthcare IT companies offering AI diagnostic platforms

Named in the bill

Public Health Service Act, 42 U.S.C. § 354(f)(1), mammography facilities, FDA (implied regulatory authority), AI/machine-learning systems, physicians

Where it stands

• Apr 27, 2026 — Introduced · Congress.gov: “Introduced in House”
• Apr 27, 2026 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.